COA 2020: Effect of Liposomal Bupivacaine vs Ropivacaine in Interscalene Block for TSA patients .
A Comparison of Liposomal Bupivacaine to Standard Ropivacaine Used in Interscalene Blocks for Patients Undergoing Total Shoulder Arthroplasty and the Effect on Postoperative Analgesia, Length of Hospitalization, and Functionality (COA HSP25)
One hundred and fifty-six patients undergoing total shoulder arthroplasty were included in this study comparing interscalene brachial plexus blockade with liposomal bupivacaine and ropivacaine or ropivacaine alone. Data was obtained from surgeries performed between June 1st 2017 and September 1st 2019. Outcomes of interest included post-operative pain scores, opioid consumption, length of hospitalization, and patient reported function. Results revealed significantly favourable post-operative pain scores from the day of surgery to post-operative day 1 in the liposomal bupivacaine group. Otherwise, no significant differences were observed between the two groups.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidencecontent for as little as $1.99 per week.
Already have an account? Log in
0 of 4 monthly FREE articles unlocked
